GB201106981D0 - Compounds for the treatment of clostridium difficle-associated disease - Google Patents
Compounds for the treatment of clostridium difficle-associated diseaseInfo
- Publication number
- GB201106981D0 GB201106981D0 GBGB1106981.2A GB201106981A GB201106981D0 GB 201106981 D0 GB201106981 D0 GB 201106981D0 GB 201106981 A GB201106981 A GB 201106981A GB 201106981 D0 GB201106981 D0 GB 201106981D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- treatment
- associated disease
- clostridium difficle
- difficle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 241000193163 Clostridioides difficile Species 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
Priority Applications (27)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1106981.2A GB201106981D0 (en) | 2011-04-27 | 2011-04-27 | Compounds for the treatment of clostridium difficle-associated disease |
EP11728027.1A EP2575968B1 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile associated disease |
HUE11728027A HUE028746T2 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile associated disease |
PCT/GB2011/000831 WO2011151621A1 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile associated disease |
JP2013512984A JP5845502B2 (en) | 2010-06-01 | 2011-06-01 | Compounds for treating Clostridium difficile-related diseases |
AU2011260097A AU2011260097B2 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile associated disease |
RS20160310A RS54781B1 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile associated disease |
EP15190275.6A EP3011960B1 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile-associated disease |
PL11728027T PL2575968T3 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile associated disease |
ES11728027.1T ES2568455T3 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of Clostridium difficile-associated disease |
BR112012030621-9A BR112012030621B1 (en) | 2010-06-01 | 2011-06-01 | compounds for the treatment of disease associated with clostridium difficile |
CA2801274A CA2801274C (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile-associated disease |
DK11728027.1T DK2575968T3 (en) | 2010-06-01 | 2011-06-01 | COMPOUNDS FOR THE TREATMENT OF Clostridium difficile-associated disease |
ES15190275T ES2803556T3 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of diseases associated with clostridium difficile |
RU2012157571/04A RU2575477C2 (en) | 2010-06-01 | 2011-06-01 | Compounds for treating clostridium difficile associated diseases |
SI201130790A SI2575968T1 (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile associated disease |
CN201180037073.2A CN103025383B (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile associated disease |
PT117280271T PT2575968E (en) | 2010-06-01 | 2011-06-01 | Compounds for the treatment of clostridium difficile associated disease |
US13/691,319 US8987308B2 (en) | 2010-06-01 | 2012-11-30 | Compounds for the treatment of Clostridium difficile-associated disease |
HK13104684.8A HK1177706A1 (en) | 2010-06-01 | 2013-04-17 | Compounds for the treatment of clostridium difficile associated disease |
HK16111340.6A HK1223032A1 (en) | 2010-06-01 | 2013-04-17 | Compounds for the treatment of clostridium difficile associated disease |
US14/620,902 US9278091B2 (en) | 2010-06-01 | 2015-02-12 | Compounds for the treatment of Clostridium difficile associated disease |
JP2015090826A JP6150841B2 (en) | 2010-06-01 | 2015-04-27 | Compounds for treating Clostridium difficile-related diseases |
US15/011,185 US20170217983A2 (en) | 2010-06-01 | 2016-01-29 | Compounds for the treatment of clostridium difficile associated disease |
HRP20160397TT HRP20160397T1 (en) | 2010-06-01 | 2016-04-18 | Compounds for the treatment of clostridium difficile associated disease |
CY20161100379T CY1117671T1 (en) | 2010-06-01 | 2016-05-06 | CLOSTRIDIUM DIFFICILE COMPLICATIONS FOR THERAPEUTIC DISEASE TREATMENT |
SM201600260T SMT201600260B (en) | 2010-06-01 | 2016-08-03 | COMPOUNDS FOR TREATING A DISEASE ASSOCIATED WITH A DIFFICULT CLOSTRIDIUM |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1106981.2A GB201106981D0 (en) | 2011-04-27 | 2011-04-27 | Compounds for the treatment of clostridium difficle-associated disease |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201106981D0 true GB201106981D0 (en) | 2011-06-08 |
Family
ID=44168569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1106981.2A Ceased GB201106981D0 (en) | 2010-06-01 | 2011-04-27 | Compounds for the treatment of clostridium difficle-associated disease |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201106981D0 (en) |
-
2011
- 2011-04-27 GB GBGB1106981.2A patent/GB201106981D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20190491T1 (en) | 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases | |
ZA201403795B (en) | Formulations for the treatment of diabetes | |
HK1197400A1 (en) | Compounds for the treatment of hiv hiv | |
EP2673286A4 (en) | Therapeutic compounds | |
AP3544A (en) | Compounds for the treatment of addiction | |
HRP20160397T1 (en) | Compounds for the treatment of clostridium difficile associated disease | |
HK1185874A1 (en) | Novel 4-amino-n-hydroxy-benzamides for the treatment of cancer 4--n-- | |
IL234796B (en) | Compounds for the treatment of ischemia-reperfusion-related diseases | |
GB201013060D0 (en) | Compounds for the treatment of clostridium difficile associated disease | |
GB201013058D0 (en) | Compounds for the treatment of clostridium difficile associated disease | |
GB201009090D0 (en) | Compounds for the treatment of clostridium difficile associated disease | |
GB201009108D0 (en) | Compounds for the treatment of clostridium difficile associated disease | |
GB201009085D0 (en) | Compounds for the treatment of clostridium difficile associated disease | |
GB201009091D0 (en) | Compounds for the treatment of clostridium difficile-associated disease | |
GB201106981D0 (en) | Compounds for the treatment of clostridium difficle-associated disease | |
GB201106972D0 (en) | Compounds for the treatment of clostridium difficile-associated disease | |
GB201106970D0 (en) | Compounds for the treatment of clostridium difficile-associated disease | |
GB201106985D0 (en) | Compounds for the treatment of clostridium difficile associated disease | |
GB201106968D0 (en) | Compounds for the treatment of clostridium difficile associated disease | |
GB201009104D0 (en) | Compounds for the treatment of clostridium difficile associated disease | |
GB201009081D0 (en) | Compounds for the treatment of clostridium difficile associated disease | |
HK1196953A1 (en) | Formulations for the treatment of diabetes | |
GB201009097D0 (en) | Compounds for the treatment of clostridium difficile-associated disease | |
GB201009095D0 (en) | Compounds for the treatment of clostridium difficile-associated disease | |
GB201119533D0 (en) | Compounds for the treatment of neoplasia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |